Surgical Robotics Technology
On April 5, 2024, Atalys announced that the company completed the acquisition of Schnipke Engraving Co., LLC. Throughout its more than 50-year history, Schnipke has established a formidable reputation as one of the pioneers in component manufacturing for highly intricate medical devices. Founded in 1967, Schnipke builds most of its production tools in-house with a team of highly experienced mold makers and engineers dedicated to crafting highly precise molds for the most demanding medical applications.
The decision to acquire Schnipke was driven by a shared vision and complementary strengths. “Like Atalys, Schnipke is a leader in the medical device manufacturing industry, renowned for its expertise, innovation, and commitment to quality,” remarked Vinc Ellerbrock, President and CEO of Atalys. “With Schnipke, we’re taking a bold step towards realizing our potential for even greater impact and success in revolutionizing medical device manufacturing,” he added.
By integrating Schnipke, Atalys gains not only Schnipke’s expertise and capabilities but also an organization that shares its passion for making a difference in the world. As a unified entity, Atalys is poised to further enhance its leadership in multiple markets not just by meeting the needs of customers, but by setting new standards and driving advancements in healthcare, through:
- Enhanced Capabilities: The integration of Schnipke’s unique strengths, especially in precision tooling, micro molding, and advanced automation capabilities, positions Atalys at the forefront of innovation in the medical device market.
- Expanded Reach: With two additional manufacturing sites in Ottoville, Ohio and Tucson, Arizona, Atalys is not only boosting production capacity but also extending its geographical footprint with a more robust manufacturing platform to serve customers, driving growth in important and major surgical markets.
- Shared Expertise: The collective knowledge and experience of the combined teams will continue to fuel innovation, improve efficiency, and enhance Atalys’ ability to solve complex challenges for its customers, opening a world of possibilities for scalable, long-term growth.
With a focus on innovation, quality, and continuous improvement, this acquisition propels Atalys to new heights, enabling the company to offer groundbreaking solutions that power medical advancements in robotic-assisted and minimally invasive surgeries through lifesaving and market-leading components in surgical stapling, access, instruments, drug delivery, vessel sealing and surgical energy.
As Mr. Ellerbrock further stated, “Our acquisition of Schnipke represents a leap towards the future of medical device manufacturing. By integrating our highly proprietary technologies and advanced automation capabilities, we’re positioned to set revolutionary standards in efficiency and precision. By combining our strengths, we’re able to deliver a broader range of services and deeper technical expertise, all underpinned by an unwavering commitment to quality, customer satisfaction, and better health outcomes.”
“This strategic expansion is more than just a milestone for us; it’s a testament to our unwavering dedication to a brighter vision for healthcare. Together, we’re setting new benchmarks for precision, quality, and performance in medical device manufacturing,” added John Hoskins, Chief Commercial and Technology Officer of Atalys. He further noted that “as we embark on this exciting new chapter, our focus remains steadfast in building a heathier world through highly-engineered patient focused technologies that alleviate pain, save lives, and expand access to better health. We’re excited about continuing to redefine what’s possible in medical device manufacturing, driven by a shared belief in the power of technology and manufacturing quality to create a healthier future for all.”
Source: Atalys
